Global Growth Factors (Blood and Tissue) Strategic

Dublin, May 23, 2018 (GLOBE NEWSWIRE) -- The "Growth Factors (Blood and Tissue) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets in US$ Million by the following Types:

• Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
• Tissue Growth Factors

The report profiles 101 companies including many key and niche players such as:

• Amgen, Inc. (USA)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Biocon Ltd. (India)
• Biogen, Inc. (USA)
• BioMimetic Therapeutics LLC (USA)
• Biopharm GmbH (Germany)
• Bolder BioTechnology, Inc. (USA)
• F. Hoffmann-La Roche AG (Switzerland)
• Chugai Pharmaceutical Co. Ltd. (Japan)
• Genentech, Inc. (USA)
• FibroGen, Inc. (USA)
• Johnson & Johnson (USA)
• Janssen Biotech, Inc. (USA)
• Lonza Group (Switzerland)
• Merck Serono (Germany)
• PeproTech, Inc. (USA)
• Reliance GeneMedix Plc (UK)
• Sangamo Therapeutics, Inc. (USA)
• Sanofi (France)
• Scil Proteins GmbH (Germany)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Wockhardt Ltd. (India)

Key Topics Covered 1. Market Overview Growth Factors: A Preface Burgeoning Global Population Offers Significant Growth Opportunities Aging Global Population: Need for New Effective Drugs Increasing Healthcare Spending in Emerging Markets: Opportunities in Store Global Spending on Medicines: A Review Biologics: Rapidly Gaining Ground List of Biosimilar Drugs Approved by the US FDA (2017) List of Biosimilar Drugs Approved by the EMA (2017) Erythropoietin (EPO) Market: An Insight Anemia in CKD and Cancer Patients: Opportunity for EPO Therapy CKD Prevalence Expanding Pool of ESRD and CKD Patients Triggers Sustained Opportunities Rising Tide of Lifestyle Diseases The Grim Reality Fueling Growth in Renal Diseases Global Diabetic Statistics Opportunity Indicators Competition in EPO Market Leading EPO Drugs Worldwide Comparison of Erythropoietin-Based Drugs in the US and European Union Safety & Efficacy Issues Concerning ESAs Serum Half-Life: A Key Attribute Differentiating ESAs Interferons Market: Rising Demand for Specialized Therapies to Drive Growth Patent Expiries of Major Interferon Drugs Colony Stimulating Factors (CSFs) Market in Myeloma Patients Neurotrophic Therapeutics: Recent Advancements & Challenges Clinical Trial Status of Neurotrophin Therapy for Major Neurodegenerative Diseases (2012) Interleukin-17 Market for Psoriasis Treatment: Positive Opportunities Anti-IL-6 Pathways for RA Treatment: Favorable Prospects Blood Growth Factors: Improving Circulation & Mobility in Peripheral Artery Disease Patients Wound Management Market and Cellular Growth Factors Growth Factors for Wound Management - A Snapshot Multiple Sclerosis Drugs Market: Competition Set to Intensify Interferon-based Drugs for HCV Treatment: An Insight Patent Expiries Fuel Competition and Sales Patent Expiries of Biopharmaceuticals in Europe and United States Innovative Delivery System Shows Potential for Accelerating Use of Growth Factors Cytokines: Vital Growth Propellers for the Future of New Drugs Brain Derived Neurotrophic Factor (BDNF) Finds Increased Application Mimetic Growth Factors Promising Potential New Technologies Challenge to Growth Factors Market Influence of Neurotrophic Factors on Brain Cell Development Side Effects Still a Concern Combination of Interferons and Ribavirin Develops More Anemia Cases Development of Cost Effective Methods Need of the Hour hMSC-based Therapies to Drive Need for Growth Factors 2. Growth Factors - An Overview Blood Growth Factors Erythropoietins Types of Erythropoietins Epoetin Darbepoetin Aranesp Aranesp Vs. Other EPOs Recombinant Human EPO (rHuEPO) Colony Stimulating Factors Granulocyte-Colony Stimulating Factor Granulocyte Macrophage-Colony Stimulating Factor Other Colony Stimulating Factors Macrophage Colony Stimulating Factor (M-CSF) Key Functions of M-CSF Side-Effects of Colony-Stimulating Factors Interferons Types of Interferons Interferon-gamma 1a and 1b: Two Key Biochemical Forms of Interferon- PEG-Intron Types of Interferons Interleukins Types of Interleukins Tissue Growth Factors Wound Healing Growth Factors Neurotrophic Growth Factors Nerve Growth Factor Vascular Endothelial Growth Factor (VEGF) Fibroblast Growth Factor (FGF) Insulin-Like Growth Factor-I (IGF-I) Insulin-Like Growth Factor-II (IGF-II) Tissue Growth Factors: Classification Based on Key Source and Principal Activity Platelet-Derived Growth Factors in Wound Healing Thrombopoietin (TPO) Growth Factors: Their Mode of Action in Tissue Repair Angiogenesis: Their Role in Wound Healing Angiogenesis as an Alternative for Cardiac Stents Applications of Growth Factors Growth Factors: Site/Course of Action and Applications 3. Product Innovations/Approvals/Introductions Chugai Receives Japanese Approval for MIRCERA Janssen Receives Breakthrough Therapy Designation from FDA for erdafitinib Bayer Receives Chinese FDA Approval for Eylea FDA Approves Breakthrough Therapy Designation for Avelumab- INLYTA Combination HumanZyme Introduces HumanKine Interferon Gamma Genentech Receives FDA Approval for Actemra FDA Approves Janssen Biotech's TREMFYA Novartis Launches Scapho in India 4. Recent Industry Activity Sanofi Acquires Bioverativ Adello Announces Acceptance of Application for Biosimilar Fligrastim by FDA Merck Divests Biosimilars Business Sangamo Changes Name to Sangamo Therapeutics 5. Focus On Select Players 6. Global Market Perspective Total Companies Profiled: 101 (including Divisions/Subsidiaries 116)

• The United States (32)
• Canada (1)
• Japan (9)
• Europe (35)
• - France (2)
• - Germany (14)
• - The United Kingdom (5)
• - Rest of Europe (14)
• Asia-Pacific (Excluding Japan) (36)
• Middle East (2)
• Latin America (1)

For more information about this report visit https://www.researchandmarkets.com/research/2...rowth?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomaterials